REMOVED: Interim Results of a Phase II Trial of Omidubicel, Ex-Vivo Expanded Umbilical Cord Blood Transplantation in Patients with Treatment-Refractory Severe Aplastic Anemia
This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been removed because it was not presented at the 2025 BMT Tandem Meeting.
Authors
- Reem Shalabi (ORCID: https://orcid.org/0000-0002-4495-5445)
- Kristen Gunn
- Brian Wells
- Jian Hur
- Jennifer Farren
- Xin Tian (ORCID: https://orcid.org/0000-0003-1896-2462)
- Georg Aue
- Neal S. Young (ORCID: https://orcid.org/0009-0007-0999-2519)
- Melissa Spencer (ORCID: https://orcid.org/0000-0003-2788-649X)
- Jennifer Wilder
- Robert Reger
- Kristen Cole
- Richard Childs
- Raquel Ríos (ORCID: https://orcid.org/0000-0003-0345-9100)
- Irina Lonskaya
Institutions
- National Institutes of Health (US)
- National Heart, Lung, and Blood Institute (US)
- National Institutes of Health Clinical Center (US)
Publication Details
- Journal
- Transplantation and Cellular Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.jtct.2025.01.067
- Citations
- 2
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 3.54